ANALYSIS ON CADJPYHello my fellow traders, hope you all are making some profits. We are here with our new analysis so that we can increase those profits for you. Let’s get into the analysis.
As we can see, the pair is currently moving in a sideways channel. so one should wait for the breakout.
Let us know your views on this in the comment section. Thank you all.
There is good news for our followers. We will be analyzing on-demand. So let us know which pair you want our analysis on and we will get it for you. Do like and follow us.
Ryan.R..Lopes
Shortsell
OAS - short sellplease show support by liking this.
I am not a financial advisor and i do not advise taking any of my trades that i post, because of the risk.
The analysis is purely for entertainment and idea what could happen with this stock.
if you have any questions feel free to ask.
+BlackStock
SELL!!!!ON WEEKLY SPINNING TOP HAS FORMED , on daily long legged dojis have been engulfed by the red , bear in mind end of the week slows momentum , but is it a coincidence that is it right at a strong resistance level , ALWAYS LOOK LEFT , LOOK LEFT!!! if price was to break below my support line at the opening of the markets and sustained a downward motion by tuesday or midweek , i think a sell is good to go , depends on one's own analysis and confidence in your analysis. shorterm target would be 1.05500 longterm??? depends on patience and personal zones
USD/CAD - Short [2:1]As you can see from my chart I'm anticipating #USDUSD to decline 32 pips to 1.3004 with a risk to reward of 2:1 .
Reason being is because we are still bearshish with a lot of seller in the market, intraday S&R has been broken & many more key factors.
Lets see how this trade plays out!
PHILL
Netflix $NFLXis Finished Growing. This Might be the Forever TopToday Netflix missed its 5 million subscriber growth BY HALF! This certainly could be a sea change for how people see the company.
So many competitors coming online. Hulu, YouTube Premium, Disney+, Apple TV+. If they can't keep subscribers now, how will they when the space gets really saturated.
On a valuation standpoint, the company is VERY expensive, trading at 50x forward earnings and has $10b in debt.
Knight-Swift $KNX Getting Ahead Of Itself on Freight-Hype. SellKnight-Swift, $KNX, the largest trucking company in the US, rallied yesterday after the earnings release of competitor J. B. Hunt $JBHT. J. B. Hunt's earnings yesterday were mostly inline, but these better-than-feared numbers eased the idea of a major transport downturn. Here's the daily chart for J. B. Hunt $JBHT.
So today, the day after that nice rally, Knight-Swift cuts its outlook pretty drastically. The cut both EPS for Q2 and Q3 down 10% of what was expected. They cite "oversupply of capacity" in the freight market which "resulted in greater than expected downward pressure on revenue per loaded mile", which is a lot of words to say that competition is eating their lunch.
In response, the stock gapped down today, but only closed down 2%. I think it's reasonable to speculate that the buyers, which were bullish on $KNX because of $JBHT's positive earnings, will now have to sell, and send the stock price back to the bottom of the range.
A sensible thesis is that if the stock can crack $34 to the downside, we may see $27-$30 in the next days after.
You can read the full article here: www.behindthebid.com
Soliton $SOLY Will Likely Trail Down Until Next CatalystSoliton reported highly anticipated results from its study on cellulite reduction on Monday, July 15th. In anticipation, the stock ran from $12 to $20, but on the day of, the stock closed down 15%.
Soliton is a small cap medical device company that has an acoustic shockwave technology for tattoo removal called Rapid Acoustic Pulse (RAP). The treatment works pretty well, needing only 2-3 visits to remove tattoos vs the standard of care (lasers) which take about 10 doctor visits. They have also put a lot of press out about the potential of using their device for cellulite.
It's worth nothing that this was their second cellulite trial. The company presented their first trial results using RAP to treat cellulite on May 11 at the National Aesthetics Conference. They also went on Yahoo Finance Video to talk about the results. The trial "succeeded" said management, however, the stock responded less than enthusiastically.
The Full Article Is At BehindTheBid.com (CLICK HERE)
Five9 Sales Execs Leaving in Droves, Will Miss Next Earnings?Yesterday the stock fell because the company's EVP of Global Sales left the company. This follows 5-6 (yes 5 to 6!) other senior enterprise sales executives and that have left in the last six months.
No company loses this many sales executives and hits their numbers. I anticipate that Five9 is going to miss next earnings pretty badly. Next earnings are on July 31st (in 14 days)
Galapagos Has Peaked, Nowhere To Go But DownGalapagos announced today a large investment and a 10-year deal with Gilead $GILD. The stock gapped due to Gilead buying 10% of Galapagos at $158/share. However, when stocks gap up on investments at a premium price, they almost always fall (see $MGI, $ARWR)
An analyst at Raymond James agrees, saying he believes $GLPG stock has now fully realized his price target by achieving his core investment thesis.
As terms of the deal, $GILD has promised not to increase their stake in Galapagos for another 10 years, so a buyout is off the table